World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
93
Citations
30454
World Ranking
974
National Ranking
86

Medicine

D-Index
96
Citations
33757
World Ranking
9669
National Ranking
940

Elizabeth Miller publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Elizabeth Miller sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 358 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Elizabeth Miller D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Elizabeth Miller sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 93 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1978 - Member of the National Academy of Sciences

Overview

Elizabeth Miller is affiliated with Public Health England in the United Kingdom. Their research primarily spans the fields of social sciences, psychology, and health professions, with significant contributions in subfields such as general health professions, clinical psychology, gender studies, and sociology and political science.

Their work covers a range of topics including intimate partner and family violence, adolescent sexual and reproductive health, sexual assault and victimization studies, child abuse and trauma, LGBTQ health, identity and policy, homicide, infanticide and child abuse, and homelessness and social issues.

Recent papers authored or coauthored by Miller include:

  • "COVID-19 and School Closures" (2020) published in JAMA
  • "Prevalence of Gender-Diverse Youth in an Urban School District" (2021) published in PEDIATRICS
  • "This Could Mean Death for My Child: Parent Perspectives on Laws Banning Gender-Affirming Care for Transgender Adolescents" (2020) published in Journal of Adolescent Health
  • "Prevention of sexual violence among college students: Current challenges and future directions" (2020) published in Journal of American College Health
  • "Transgender Youths' Perspectives on Telehealth for Delivery of Gender-Affirming Care" (2020) published in Journal of Adolescent Health

Frequent collaborators with Miller include Robert W. S. Coulter, Maya I. Ragavan, Alison J. Culyba, Kaleab Z. Abebe, and Kelley A. Jones. Their research appears extensively in the following publication venues:

  • Journal of Adolescent Health
  • Journal of Interpersonal Violence
  • Academic Pediatrics
  • Journal of Family Violence
  • Journal of Women's Health

Miller's work often addresses critical public health and social issues concerning vulnerable populations, especially youth and marginalized groups. The focus on adolescent health, gender identity, and violence indicates an interdisciplinary approach combining clinical, psychological, and social research perspectives.

Notably, Miller was recognized as a Member of the National Academy of Sciences in 1978, reflecting a longstanding engagement in scientific inquiry. Their publication record, spanning over two hundred articles, demonstrates consistent productivity across several highly specialized topics within health and social sciences.

Best Publications

  • Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association

    Brent Taylor;Elizabeth Miller;CPaddy Farrington;Maria-Christina Petropoulos

  • IMMUNIZATION OF LOW DENSITY LIPOPROTEIN (LDL) RECEPTOR-DEFICIENT RABBITS WITH HOMOLOGOUS MALONDIALDEHYDE-MODIFIED LDL REDUCES ATHEROGENESIS

    Wulf Palinski;Elizabeth Miller;Joseph L. Witztum

  • Effectiveness of maternal pertussis vaccination in England: an observational study

    Gayatri Amirthalingam;Nick Andrews;Helen Campbell;Sonia Ribeiro

  • Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

    Elizabeth Miller;Katja Hoschler;Pia Hardelid;Elaine Stanford

  • Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

    Sohvi Hörkkö;David A. Bird;Elizabeth Miller;Hiroyuki Itabe

  • Consequences of confirmed maternal rubella at successive stages of pregnancy

    Elizabeth Miller;John E. Cradock-Watson;Thomas M. Pollock

  • Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases

    G. Enders;I. Bolley;E. Miller;J. Cradock-Watson

  • CONSEQUENCES OF CONFIRMED MATERNAL RUBELLA AT SUCCESSIVE STAGES OF PREGNANCY

    Elizabeth Miller;JohnE. Cradock-Watson;ThomasM. Pollock

  • Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

    Elizabeth Miller;Nicholas J Andrews;Pauline A Waight;Mary P E Slack

  • Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging

    Anat Ben-Zvi;Elizabeth A. Miller;Richard I. Morimoto

  • Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

    Caroline L Trotter;Nick J Andrews;Edward B Kaczmarski;Elizabeth Miller

  • Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

    Pauline A Waight;Nicholas J Andrews;Shamez N Ladhani;Carmen L Sheppard

  • Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40

    Wendy A. Knowles;Pam Pipkin;Nick Andrews;Andrew Vyse

  • Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

    E. Miller;D. Salisbury;M. Ramsay

  • Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

    Nick J Andrews;Pauline A Waight;Polly Burbidge;Emma Pearce

  • Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

    Shamez N Ladhani;Shamez N Ladhani;Sarah Collins;Abdelmajid Djennad;Carmen L Sheppard

  • Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

    Mary E Ramsay;Nick J Andrews;Caroline L Trotter;Edward B Kaczmarski

  • Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

    Brent Taylor;Elizabeth Miller;Raghu Lingam;Nick Andrews

  • Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

    Mary E Ramsay;Nick Andrews;Edward B Kaczmarski;Elizabeth Miller

  • Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis

    Unknown

  • Increasing hospital admissions for pneumonia, England.

    Caroline L. Trotter;James M. Stuart;Robert George;Elizabeth Miller

  • Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.

    Ray Borrow;Nick Andrews;David Goldblatt;Elizabeth Miller

  • Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England

    Nick Andrews;Ray Borrow;Elizabeth Miller

  • Immediate and long term outcome of human parvovirus B19 infection in pregnancy

    Elizabeth Miller;Christopher K. Fairley;Bernard J. Cohen;Claude Seng

  • Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

    Jamie Findlow;Ray Borrow;Matthew D. Snape;Tom Dawson

  • Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association

    B Taylor;E Miller;CP Farrington;M-C Petropoulos

Frequent Co-Authors

Pauline Waight
Pauline Waight Public Health England
Nick Andrews
Nick Andrews Salk Institute for Biological Studies
Ray Borrow
Ray Borrow Manchester Royal Infirmary
David Goldblatt
David Goldblatt University College London
Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Mary P. E. Slack
Mary P. E. Slack Griffith University
Richard Pebody
Richard Pebody Public Health England
Mark Jit
Mark Jit New York University
W. John Edmunds
W. John Edmunds London School of Hygiene & Tropical Medicine
Paul T. Heath
Paul T. Heath St George's, University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related fields like nursing can offer diverse career opportunities. Many professionals in healthcare decide to enhance their qualifications through specialized nursing programs. For those considering an advanced nursing degree, programs such as the cheapest psychiatric nurse practitioner programs provide affordable options to gain expertise in mental health care, an area closely linked to immunological disorders.

Nurses aiming to boost their salaries and job prospects often research earning potential. According to data, understanding how much do DNP nurses make can help in making informed decisions about investing in advanced degrees.

For nurse practitioners seeking to specialize further, bridge programs like the FNP to ACNP bridge program online offer flexible routes to transition from family nursing to acute care, aligning well with the demands of immunology-related patient care.

Additionally, accelerated pathways exist for those wanting to enter the nursing workforce quickly. The accelerated NP programs allow students to fast-track their education and begin working in specialized healthcare roles sooner.

Best Scientists Citing Elizabeth Miller

Trending Scientists

Recently Published Articles